ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,683,452 | -29.7% | 3,409,446 | -1.2% | 0.00% | -100.0% |
| Q2 2023 | $22,296,030 | -78.4% | 3,451,398 | -74.8% | 0.00% | -66.7% |
| Q1 2023 | $103,254,984 | -26.4% | 13,694,295 | -1.1% | 0.00% | -25.0% |
| Q4 2022 | $140,320,780 | +12.9% | 13,852,002 | +10.2% | 0.00% | 0.0% |
| Q3 2022 | $124,310,000 | -1.3% | 12,569,140 | +6.3% | 0.00% | 0.0% |
| Q2 2022 | $125,940,000 | +427.8% | 11,825,332 | +383.2% | 0.00% | +300.0% |
| Q1 2022 | $23,861,000 | -29.5% | 2,447,299 | +3.4% | 0.00% | 0.0% |
| Q4 2021 | $33,852,000 | +73.0% | 2,367,242 | +142.4% | 0.00% | 0.0% |
| Q3 2021 | $19,571,000 | -0.8% | 976,587 | +8.8% | 0.00% | 0.0% |
| Q2 2021 | $19,738,000 | -32.1% | 897,187 | +4.9% | 0.00% | 0.0% |
| Q1 2021 | $29,052,000 | +106.0% | 855,473 | +144.1% | 0.00% | – |
| Q4 2020 | $14,102,000 | – | 350,417 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |